Food and Drug Administration to treat obesity
Serhan CN, Bck M, Chiurchi V, Hersberger M, Mittendorfer B, Calder PC, et al
Common GLP-1 medications include: These medications are typically taken as weekly injections under medical supervision
That can be incredibly meaningful, especially for people who have spent years being told, directly or indirectly, that weight is simply a matter of willpower
The study established that four hour intravenous infusions of GLP-1 (7-36) completely normalised blood glucose levels of patients with type 2 diabetes admitted to hospital for insulin therapy (Nauck, Klein, rskov)
Novo Nordisk has also cited indirect comparison data suggesting that fewer patients discontinued oral semaglutide due to side effects compared with orforglipron, though the companies and independent commentators note the significant methodological limitations of such comparisons in the absence of a head-to-head obesity trial